Tudor Investment Corp’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-36,975
Closed -$169K 2258
2025
Q1
$169K Buy
+36,975
New +$169K ﹤0.01% 1421
2024
Q4
Sell
-41,544
Closed -$201K 2141
2024
Q3
$201K Sell
41,544
-1,105
-3% -$5.35K ﹤0.01% 1412
2024
Q2
$208K Buy
42,649
+925
+2% +$4.51K ﹤0.01% 1361
2024
Q1
$554K Buy
+41,724
New +$554K ﹤0.01% 1074
2023
Q4
Sell
-31,744
Closed -$421K 1992
2023
Q3
$421K Buy
31,744
+901
+3% +$11.9K ﹤0.01% 1166
2023
Q2
$578K Sell
30,843
-8,931
-22% -$167K 0.01% 1085
2023
Q1
$574K Buy
39,774
+13,489
+51% +$195K 0.01% 1095
2022
Q4
$509K Buy
+26,285
New +$509K 0.01% 1110
2022
Q2
Sell
-24,216
Closed -$553K 1984
2022
Q1
$553K Buy
+24,216
New +$553K 0.01% 1064
2021
Q3
Sell
-7,904
Closed -$476K 1996
2021
Q2
$476K Buy
+7,904
New +$476K 0.01% 1128